Presentation TCT 2019 Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems? Presenter: Philippe Pibarot September 26, 2019 REGISTER for free or LOG IN to view this content Up Next Presentation TCT 2019 Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward Presenter: Ian Meredith AM September 26, 2019 More slides + Presentation TCT 2019 Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches Presenter: Gregg Stone September 26, 2019 Presentation TCT 2019 Utility of Coronary Physiology Assessment in the Asymptomatic Patient Presenter: Stephane Fournier September 26, 2019 We Recommend Structural Heart Presentation TCT 2019 Aortic Valve
Presentation TCT 2019 Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward Presenter: Ian Meredith AM September 26, 2019
Presentation TCT 2019 Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches Presenter: Gregg Stone September 26, 2019
Presentation TCT 2019 Utility of Coronary Physiology Assessment in the Asymptomatic Patient Presenter: Stephane Fournier September 26, 2019